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Oxygen tension modulates beta-globin switching in embryoid
bodies
Abstract
Little is known about the factors influencing the hemoglobin switch in vertebrates during development.
Inasmuch as the mammalian conceptus is exposed to changing oxygen tensions in utero, we examined
the effect of different oxygen concentrations on beta-globin switching. We used an in vitro model of
mouse embryogenesis based on the differentiation of blastocyst-derived embryonic stem cells to
embryoid bodies (EBs). Cultivation of EBs at increasing oxygen concentrations (starting at 1% O2) did
not influence the temporal expression pattern of embryonic (betaH1) globin compared to the normoxic
controls (20% O2). In contrast, when compared to normoxically grown EBs, expression of fetal/adult
(betamaj) globin in EBs cultured at varying oxygen concentrations was delayed by about 2 days and
persisted throughout differentiation. Quantitation of hemoglobin in EBs using a
2,7-diaminofluorene-based colorimetric assay revealed the appearence of hemoglobin in two waves, an
early and a late one. This observation was verified by spectrophotometric analysis of hemoglobin within
single EBs. These two waves might reflect the switch of erythropoiesis from yolk sac to fetal liver.
Reduced oxygenation is known to activate the hypoxia-inducible factor-1 (HIF-1), which in turn
specifically induces expression of a variety of genes among them erythropoietin (EPO). Although EBs
increased EPO expression upon hypoxic exposure, the altered beta-globin appearance was not related to
EPO levels as determined in EBs overexpressing EPO. Since mRNA from both mouse HIF-1alpha
isoforms was detected in all EBs tested at different differentiation stages, we propose that HIF-1
modulates beta-globin expression during development.
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ABSTRACT Little is known about the factors influenc-
ing the hemoglobin switch in vertebrates during develop-
ment. Inasmuch as the mammalian conceptus is exposed
to changing oxygen tensions in utero, we examined the
effect of different oxygen concentrations on b-globin
switching. We used an in vitro model of mouse embryo-
genesis based on the differentiation of blastocyst-derived
embryonic stem cells to embryoid bodies (EBs). Cultiva-
tion of EBs at increasing oxygen concentrations (starting
at 1% O2) did not influence the temporal expression
pattern of embryonic (bH1) globin compared to the
normoxic controls (20% O2). In contrast, when compared
to normoxically grown EBs, expression of fetal/adult
(bmaj) globin in EBs cultured at varying oxygen concen-
trations was delayed by about 2 days and persisted
throughout differentiation. Quantitation of hemoglobin
in EBs using a 2,7-diaminofluorene-based colorimetric
assay revealed the appearence of hemoglobin in two
waves, an early and a late one. This observation was
verified by spectrophotometric analysis of hemoglobin
within single EBs. These two waves might reflect the
switch of erythropoiesis from yolk sac to fetal liver.
Reduced oxygenation is known to activate the hypoxia-
inducible factor-1 (HIF-1), which in turn specifically in-
duces expression of a variety of genes among them
erythropoietin (EPO). Although EBs increased EPO ex-
pression upon hypoxic exposure, the altered b-globin
appearance was not related to EPO levels as determined
in EBs overexpressing EPO. Since mRNA from both
mouse HIF-1a isoforms was detected in all EBs tested at
different differentiation stages, we propose that HIF-1
modulates b-globin expression during development.—
Bichet, S., Wenger, R. H., Camenisch, G., Rolfs, A.,
Ehleben, W., Porwol, T., Acker, H., Fandrey, J., Bauer, C.,
Gassmann, M. Oxygen tension modulates b-globin
switching in embryoid bodies. FASEB J. 13, 285–295
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For decades, mammalian hematopoiesis has been
studied extensively in mouse models. The mouse
erythropoietic system is derived from the mesoder-
mal germ layer and its development starts at day 6.5
postcoitum (reviewed in ref 1). Changes in globin
gene expression, erythropoietic sites, and erythro-
blast morphology are hallmarks of mammalian eryth-
ropoiesis during development. Due to its complexity,
b-globin switching from embryonic to fetal/adult
globin synthesis is not fully understood. It is assumed
that erythroid-specific and/or ubiquitous factors
bind to locus control region elements and/or pro-
moters. Attempts to unravel the signaling mecha-
nisms that mediate activation of required genes at
the appropriate times have had limited success (re-
viewed in ref 2). Compared to the human and
ruminant fetus, where b-globin represents the pri-
mary globin species during fetal life, the gene switch
in mice proceeds from embryonic to adult globin
expression without a fetal period.
The mouse b-like globin gene cluster resides on
chromosome 7 and consists of five actively tran-
scribed genes (ey, bH0, bH1, b
maj, bmin), which are
expressed in a stage-specific manner (3, 4). During
embryonic and fetal development, erythropoiesis is
subjected to rapid changes. At day 7.5 of gestation,
embryonic ey- and bH1-globin genes are expressed
in nucleated cells of blood islands that begin to form
in the central area of the egg cylinder (5). By day 9,
a primitive capillary plexus is formed, allowing these
cells to enter the circulation (6). The egg cylinder/
yolk sac remains the primary site of blood formation
until approximately midgestation. After this stage,
yolk sac erythropoiesis declines; at day 10.5 of gesta-
tion, the fetal liver becomes the major organ for
erythropoiesis until late gestation (reviewed in ref 7).
Non-nucleated erythrocytes of hepatic origin, enter-
ing circulation at about day 12 postcoitum, contain
both forms of fetal/adult globin (bmaj and bmin) (8).
Finally, starting at day 16–17 of development, the
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site of erythropoiesis is again switched to bone
marrow and spleen.
The establishment of an in vitro model of mouse
embryogenesis based on differentiating embryonic
stem (ES)2 cells has facilitated the investigation of
several aspects of mouse development (reviewed in refs
9, 10). ES cells are derived from the inner cell mass of
blastocysts and can be cultivated in vitro without losing
their pluripotency by addition of the leukemia inhibi-
tory factor (LIF) (11). In the absence of LIF, ES cells
differentiate spontaneously, thereby forming 3-dimen-
sional structures termed embryoid bodies (EBs) (12).
These embryo-like structures are known to contain
derivatives from the three primitive germ layers. Pluri-
potent ES cells undergo differentiation resulting in
various committed cell types, including hematopoietic
precursors (9, 10). Keller and co-workers (13) recently
reported that primitive erythrocytes and other hema-
topoietic lineages arise from a common ES cell-derived
precursor within EBs.
We sought to analyze whether changes in oxygen
supply affect globin switching during mammalian
development. The rationale is that during early
embryogenesis, the peri-implantation embryo re-
sides in the uterus with reduced oxygen tension (14)
whereas upon vascularization of the developing fe-
tus, oxygen supply to the conceptus increases. Previ-
ous reports showing that EBs express the full com-
plement of mouse embryonic globin genes and that
a switch occurs to fetal/adult globin genes (15, 16)
made this system seem attractive for our purposes.
Indeed, we recently demonstrated that EBs are able
to sense changes in oxygen concentrations and spe-
cifically respond to reduced oxygenation by in-
creased expression of the oxygen-regulated genes
vascular endothelial growth factor and aldolase A
(17). In this work, we provide evidence that b-globin




The ES cell line CCE (18) was grown on gelatin-coated dishes
exactly as described (19). The day after passaging (referred to
as day 0 of differentiation), 300–800 ES cells/ml were al-
lowed to differentiate in a methylcellulose medium, as de-
scribed (17). Oxygen tensions in the incubator (Forma
Scientific, Marietta, Ohio) were 140 mm Hg (20% O2 v/v,
normoxia) and 28 or 7 mm Hg (4 or 1 % O2 v/v, respectively,
hypoxia), as indicated. For stable transfection experiments,
the human erythropoietin overexpression vector pTREPO
was constructed by inserting the 1.2 kb EcoRI cDNA fragment
from pe49f (a kind gift from C. Shoemaker) into the EcoRI
site of pTR. The expression vector pTR contains the strong
SRa promoter/enhancer (20), SV40 splice and polyadenyla-
tion sites, and a neomycin-resistance gene driven by RSV-LTR
sequences (R. H. Wenger, unpublished results). After linear-
ization with XmnI, 50 mg plasmid DNA was transfected into
1 3 107 CCE ES cells by electroporation at 960 mF and 250 V
in a 0.4 cm cuvette (GenePulser, BioRad, Richmond, Calif.).
Stable transfectants were selected with 0.5 mg/ml G418
(Gibco-BRL, Gaithersburg, Md.); resistant clones were ana-
lyzed for EPO expression by Northern blotting (see below)
and radioimmunoassy (21).
mRNA analysis
EBs were collected at the indicated time points, diluted with
2 volumes of Iscove’s modified Dulbecco’s medium (IMDM),
and centrifuged at 150 3 g for 10–20 min at 4°C. Subse-
quently, RNA was isolated from the pellet (22) and Northern
blotting was performed, as described previously (23), using 10
mg of total RNA. Both the bH1-globin probe obtained by
reverse transcriptase-polymerase chain reaction (RT-PCR)
from 13-day mouse yolk sac RNA and the bmaj-globin probe
generated from the genomic clone GSE428 (16) were kindly
provided by M. V. Wiles. The EPO probe was derived from the
plasmid pe49f. The probe for the ribosomal protein L28 (24)
was used for control hybridizations.
The two mRNA isoforms encoding mouse hypoxia-induc-
ible factor-1a (HIF-1a) were detected by RT-PCR, as de-
scribed previously (25). Two different forward primers, spe-
cific for either exon I.1 or exon I.2, and a common reverse
primer specific for exon III were used. EPO mRNA in EBs was
quantitated by competitive RT-PCR, using a synthetic EPO
cRNA template as competitor (21). Human and mouse EPO
mRNA within the transfected EBs was analyzed by RT-PCR,
each using one EPO primer set specific for human or mouse
EPO mRNA. The amplification profile was 94°C for 60 s, 55°C
for 60 s, and 72°C for 100 s. RT-PCR products were 395 bp
and 280 bp for mouse (35 cycles) and human (30 cycles)
EPO, respectively.
Protein analysis
Expression of the two HIF-1 protein subunits, HIF-1a, and
aryl hydrocarbon receptor nuclear translocator (ARNT; HIF-
1b) was examined by Western blot analysis. Nuclear extracts
(25 mg) derived from ES cells were separated by 7.5% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and electrotransferred onto nitrocellulose. The HIF-1
subunits were detected using a chicken polyclonal antibody
raised against human HIF-1a (26) and a polyclonal rabbit
antibody raised against ARNT (kindly provided by Y. Fujii-
Kuriyama). The blots were subsequently incubated with a
secondary rabbit anti-chicken (G1351, Promega, Madison,
Wis.) or a goat anti-rabbit antibody coupled to horseradish
peroxidase (Pierce, Rockford, Ill.) and developed with Super-
Signal CL-HRP chemiluminescence substrate (Pierce).
DNA binding activity of HIF-1 was determined by electro-
phoretic mobility shift assay (EMSA) as described previously
(27). Briefly, nuclear extracts were prepared from normoxic
and hypoxic ES cell cultures and incubated with a radioac-
tively labeled oligonucleotide derived from the oxygen-re-
sponsive EPO 39 enhancer. Where indicated, the monoclonal
anti-HIF-1a antibody mgc3 (26) or the monoclonal anti-
2 Abbreviations: ARNT, aryl hydrocarbon receptor nuclear
translocator; DAF, 2,7-diaminofluorene; EBs, embryoid bod-
ies; EMSA, electrophoretic mobility shift assay; EPO, erythro-
poietin; EPO-R, EPO receptor; ES, embryonic stem; hEPO,
human EPO; HIF, hypoxia-inducible factor; IMDM, Iscove’s
modified Dulbecco’s medium; LIF, leukemia inhibitory fac-
tor; PAGE, polyacrylamide gel electrophoresis; RT-PCR, re-
verse transcriptase-polymerase chain reaction.
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ARNT antibody 2B10 (kindly provided by G.H. Perdew) were
subsequently added to the binding reaction. The reaction
mixtures were separated by nondenaturing PAGE and the
dried gels were evaluated by phosphorimaging (Molecular
Dynamics, Sunnyvale, Calif.).
Hemoglobin quantitation
At appropriate time points, 100–3000 EBs were collected,
counted, diluted with 2 volumes IMDM, and centrifuged at
150 3 g for 10–20 min. The pellet was resuspended in 2 ml
dispase II (2.4 U/ml) (Boehringer-Mannheim), supple-
mented with 0.1 U/ml of collagenase, and incubated at 37°C
for 10–20 min. After cell counting using the trypan blue
exclusion method (0.4% (w/v) in phosphate-buffered saline)
to assess cell viability, the dissociated cells were lysed in 550 to
600 ml 0.01% (v/v) NP-40 in water (Fluka, St. Louis, Mo.).
One aliquot of the cell lysate was used for protein quantita-
tion (BioRad). The other aliquot was used to determine the
hemoglobin concentration in the dissociated cells. To this
end, we modified a 2,7-diaminofluorene (DAF) colorimetric
assay, which is based on the oxidative transition of DAF to
fluorene blue by the pseudoperoxidase activity of hemoglo-
bin (28). A mixture of 15 ml of 1% DAF (w/v) (Sigma, St.
Louis, Mo.) in 90% glacial acetic acid with 1.5 ml of assay
buffer (100 mM Tris phosphate buffer, pH 7.0, 6 M urea,
0.18% w/v H2O2) was added to 500 ml of the supernatant of
the lysed cells. After incubation for 12 min at 25°C, the
absorbance was measured at 610 nm. Fresh mouse blood was
used as hemoglobin standard.
Spectrophotometry
Whole mount light absorption photometry was performed as
described previously (29). In brief, EBs at differentiation days
7–15 were placed in a superfusion chamber (30) on a small
bench containing small holes of about the same diameter as
the EBs. Isotonic salt solutions containing 5 mM glucose were
equilibrated with different O2/CO2/N2 mixtures in order to
adjust varying oxygen tensions at pH 7.4 (10 ml/min at 36°C).
EBs were supplied symmetrically with nutrients by this proce-
dure. The superfusion chamber was mounted on the stage of
a light microscope for light absorption measurements. Light
from a halogen bulb (12 V, 100 W) transilluminated the EBs
only, since the bench was made opaque by spattering with
gold to avoid uncharacteristic light scattering. Following this
procedure, only the light coming through the EB’s tissue into
the objective (403) was recorded by a photodiode-array
spectrophotometer (MCS 210, Zeiss) connected to the third
ocular of the microscope trinocular head via a light guide.
Difference spectra (anaerobic vs. aerobic steady-state) were
recorded by defining 20% O2, 3% CO2 and 77% N2 equili-
brating conditions in the superfusion medium as reference
(aerobic steady-state), which was automatically subtracted
from the spectra recorded under reducing conditions by
equilibrating the superfusion medium with 3% CO2 and 97%
N2. The recorded spectra were evaluated as described previ-
ously (29).
RESULTS
Temporal expression pattern of embryonic (bH1)
and fetal/adult (bmaj) globin mRNA in EBs
cultured at 20% oxygen
To define the temporal embryonic (bH1) and fetal/
adult (bmaj) globin expression pattern in developing
EBs grown at normoxic conditions (20% O2), ES cells
were allowed to differentiate in the absence of LIF in
an methylcellulose-containing medium. The use of
such a semi-solid differentiation system has been de-
scribed to allow synchronous differentiation of the ES
cells (31). Northern blot analysis detected bH1 globin
mRNA as early as at day 5 of differentiation, with a peak
at day 8, followed by barely detectable levels beyond
day 10 (Fig. 1A). This temporal order of appearance
and disappearance is comparable to previous reports
Figure 1. Northern blot analysis of embry-
onic (bH1) and fetal/adult (bmaj) globin
mRNA in growing EBs. A) EBs were de-
rived from wild-type ES cells and cultured
exclusively at 20% oxygen. B) Wild-type ES
cell-derived EBs were cultured at 1, 4, and
20% oxygen as indicated. Each 10 mg of
total RNA extracted from growing EBs at
different time points were analyzed for
bH1 and bmaj-globin expression by North-
ern blotting. A ribosomal protein L28
probe was used as a control for loading
and transfer efficiency.
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showing bH1-globin mRNA expression in EBs at differ-
entiation day 4 (assessed by RT-PCR analysis; ref 32) or
day 5 (assessed by RNase protection assay; ref 16) and
decreasing to very low levels after day 12 of EB differ-
entiation (assessed by RNase protection assay; ref 15).
The expression of fetal/adult (bmaj) globin
mRNA was first detected after 5– 6 days of differ-
entiation, peaked at day 10, and decreased contin-
uously (but less substantially than the embryonic
globin mRNA level) until it could no longer be
detected after day 16 (Fig. 1A). The expression
pattern of bmaj-globin also agrees with previous
reports in which low mRNA signals were detected
in EBs as early as day 4 (32), increasing over the
ensuing days and dropping to undetectable levels
after day 15 (15). Thus, the b-globin expression
pattern is highly reproducible in EBs.
b-Globin switching is dependent on the oxygen
concentration
Because the conceptus experiences changes in oxy-
gen supply during development, we sought to ana-
lyze whether increasing oxygen concentrations influ-
ence b-globin switching in EBs. To recapitulate the
in utero oxygenation conditions to a given extent,
EBs were cultured at varying oxygen concentrations,
as described (17). In brief, EBs were exposed to 1%
O2 for 72 h, switched to 4% O2 for an additional
96 h, and finally switched to 20% O2 until differen-
tiation day 18. Compared to the normoxic cultiva-
tion of EBs, these changes in oxygen concentration
did not influence the average number of viable cells
forming an EB (data not shown). Total RNA ex-
tracted from the EBs cultured at increasing oxygen
concentrations was analyzed for embryonic and fe-
tal/adult b-globin mRNA expression by Northern
blotting. Similar to the EBs shown in Fig. 1A, specific
bH1-globin mRNA was detected as early as at day 5 of
differentiation, showed a peak at day 8, and de-
creased after day 10 (Fig. 1B). In contrast to nor-
moxically cultured EBs, the appearance of bmaj-
globin mRNA was delayed by about 2 days, showed
weak signals until day 8 of differentiation, and
reached a plateau at day 12 that, unlike normoxically
grown EBs, persisted until day 18 when the experi-
ment was terminated (Fig. 1B).
Kinetic analysis of hemoglobin protein formation
in differentiating EBs
Quantitation of hemoglobin concentration in EBs
grown at increasing concentrations of oxygen was
performed by means of a DAF-based colorimetric
assay (28, 33) adapted for hemoglobin detection in
EBs (19). DAF colorimetry is less hazardous and
more sensitive than the benzidine-based method.
Figure 2 shows hemoglobin concentrations in EBs
from four independent experiments. No hemoglo-
bin was detected within the first 4 days of differenti-
ation. Between days 5 and 9 we observed a first wave
of hemoglobin production, peaking at days 5–7 with
a hemoglobin concentration of about 1.1–2.6 pg/
cell. A second increase in hemoglobin was observed
from day 12 until day 18, when the experiment was
terminated.
Since the DAF-based (as well as the benzidine-
based) hemoglobin colorimetric assay relies on the
pseudoperoxidase activity of hemoglobin, we sought
to verify these results by spectrophotometric analysis
of hemoglobin within single EBs. Figure 3A shows an
anaerobic (N2-saturated perfusion medium) vs. aer-
obic steady-state spectrum of EBs at differentiation
days 15 and 11. The difference spectrum at day 15
was dominated by hemoglobin with typical troughs
at 538 nm and 577 nm and peaked at 554 nm and
590 nm, as indicated by the superimposed difference
spectrum of isolated mouse hemoglobin (dotted
line). This corresponds well with anaerobic vs. aero-
bic steady-state spectra of single EBs at the differen-
tiating ages of 7 or 8 and, although less pronounced,
13 days, as shown in Fig. 3B. The different variations
indicate different signal-to-noise ratios due to vary-
ing hemoglobin contents that peaked at days 8 and
15. The single peaks of the anaerobic vs. aerobic
steady-state difference spectrum of the EB at day 11
(Fig. 3A) coincide with the characteristic peaks of
reduced cytochrome c (552 nm), cytochrome b (563
nm), and cytochrome aa3 (605 nm) of the respira-
tory chain as indicated by the different spectra of
isolated cytochrome c, b, aa3, appearing as shadowed
curves in Fig. 3A (34). This observation indicates that
Figure 2. DAF-based quantitation of hemoglobin in EBs
cultured at varying oxygen concentrations. At the indicated
time points, EBs were harvested and the pseudoperoxidase
activity of hemoglobin was determined by DAF colorimetry.
In all four independent experiments, EBs were cultured at
increasing oxygen concentrations as indicated.
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the hemoglobin content at day 11 is very low. In
summary, the pattern of appearance, disappearance,
and reappearance of hemoglobin, as exemplified in
Fig. 3B, very closely resembles the one obtained by
DAF colorimetry. EBs apparently generate two waves
of hemoglobin, an early and a late one.
The hypoxia-inducible factor-1 (HIF-1) is
expressed in ES cells and EBs
From fertilization until delivery, cells contributing to
the embryo face continuous changes in oxygen sup-
ply (14). Reduced oxygenation is known to activate
HIF-1, a heterodimeric transcription factor consist-
ing of the specific HIF-1a subunit and the common
heterodimerization partner ARNT (HIF-1b) (re-
viewed in refs 35, 36). Activation of HIF-1 in turn
results in induced expression of a variety of genes
including erythropoietin (EPO), vascular endothe-
lial growth factor, transferrin, and glycolytic enzymes
(35). Thus, one might expect that reduced oxygen-
ation influences expression of hypoxically regulated
genes in the growing conceptus, thereby perhaps
modulating developmental mechanisms such as
b-globin switching.
As a first step, we tested normoxic (20% O2) and
hypoxic (1% O2 for 4 h) ES cells for expression of
HIF-1a and ARNT (HIF-1b) by Western blot analysis.
In view of their characteristic feature to grow in
clumps, ES cells were generally grown to 30–50%
confluency only, thereby avoiding the formation of a
hypoxic microenvironment in normoxically cultured
cells. Although ARNT (but no HIF-1a) protein could
be detected in nuclear extracts derived from nor-
moxic cells, both HIF-1 subunits appeared upon
hypoxic exposure of the cells (Fig. 4A). To test the
ability of ES cells to form a functional HIF-1 com-
plex, we performed EMSAs using an HIF-1 binding
oligonucleotide derived from the 39 region of the
EPO gene (27). As shown in Fig. 4B and as we
reported previously (37, 38), a constitutive and a
nonspecific factor present in normoxic cell extracts
bound the HIF-1 probe. An additional DNA binding
activity resulting in retarded electrophoretic mobility
appeared exclusively in hypoxic ES cell extracts.
Supershift experiments using monoclonal antibodies
against HIF-1a and ARNT confirmed the identity of
HIF-1. Very recently, the ES cell line J1 has been
reported to express HIF-1a in nonhypoxic culture
conditions (39). However, further analysis of three
additional unrelated ES cell lines exposed to hypoxia
or normoxia confirmed our results shown in Fig. 4A,
B (I. Kvietikova, D. Chilov, and M.Gassmann, unpub-
lished results). Thus, the constitutive expression of
HIF-1a appears to be a specific property of J1 cells
that is not shared by other ES cells analyzed so far.
Next, we tested our developing EBs for the pres-
ence of HIF-1a mRNA. As reported previously, mice
express two different HIF-1a isoforms that contain
alternative first exons (25, 40). These two mRNAs
give rise to two predicted translation products differ-
ing in the translational start site by 12 amino acids.
Therefore, we used an RT-PCR approach capable of
distinguishing between the two HIF-1a mRNA iso-
forms (25). As shown in Fig. 4C, both mRNAs were
expressed at approximately constant ratios in all
differentiating EBs tested. Together, ES cells pro-
duce HIF-1 in an oxygen-dependent manner and
HIF-1 isoforms are expressed throughout differenti-
ation to EBs, suggesting that HIF-1 might regulate
expression of a variety of genes during EB develop-
ment.
EPO is up-regulated in hypoxic EBs but does not
influence b-globin switching
HIF-1 mediates hypoxic up-regulation of the hema-
topoietic growth factor EPO, which is known to
regulate survival, proliferation, and differentiation of
erythroid progenitor cells upon binding to the EPO
receptor (EPO-R) (reviewed in refs 41, 42). Null
mutant mice lacking either EPO or EPO-R have been
reported to exhibit altered yolk sac erythropoiesis to
some extent, but a drastic reduction of definitive
erythropoiesis in the fetal liver leading to embryonic
death at day 13–13.5 postcoitum (43, 44). Thus, the
effects of EPO on primitive and definitive erythro-
poiesis are substantially different. Since EPO is reg-
ulated in an oxygen-dependent manner, one might
envision that upon hypoxic stimulation of EBs, EPO
might differentially regulate embryonic and fetal/
adult globin expression.
To test this notion, we first determined by means
of RT-PCR whether EPO and EPO-R mRNA were
both expressed in our developing EBs. In agreement
with previous reports (19, 31, 32, 45), specific EPO
and EPO-R mRNA were detected at comparable
levels in EBs during all stages of differentiation
examined (Fig. 5A). Hypoxic inducibility of EPO was
analyzed by measuring EPO mRNA levels in 9-day-
old EBs that were preincubated at 20% or 1% oxygen
for 24 h prior to exposure to 1% or 20% oxygen,
respectively, for 4 h. Using a synthetic EPO cRNA as
competitor template (21), we showed for the first
time by competitive RT-PCR analysis that EPO
mRNA was reversibly increased by a factor of 6 in EBs
when exposed to hypoxia (Fig. 5B). To detect a
putative function of EPO on b-globin switching
directly and to avoid exposure of EBs to hypoxia,
which in turn induces expression of a variety of other
genes, we established an EPO-overexpressing ES cell
subclone. Since human EPO (hEPO) is able to
activate mouse erythropoiesis (41), we linked the
hEPO cDNA to the SRa promoter/enhancer se-
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Figure 3. Anaerobic vs. aerobic steady-state light absorption difference spectra of single EBs at differentiation day 7, 8, 11, 13,
and 15 days. A) The correlation of the experimental spectrum of isolated adult mouse hemoglobin (dotted line) and of single
EBs at day 11 to the redox spectra of isolated mitochondrial cytochromes c, b, and aa3. Whereas peaks and troughs of the
spectrum at day 15 coincide well with the hemoglobin spectrum, the spectrum taken at day 11 is clearly influenced by
mitochondrial cytochromes without any visible contamination by hemoglobin. B) Time sequence of the spectra recorded at
distinct differentiation days of EBs (n55–7). Spectra are shown as mean curves (continuous line) with the corresponding single
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quence that we had previously reported to efficiently
overexpress a reporter gene in the 1C11 cell subline,
a derivative of the mouse embryonic carcinoma (EC)
cell line F9 (20). Of note, EC cells closely resemble
ES cells. Northern blot analysis revealed the pres-
ence of hEPO mRNA in three stably transfected ES
cell subclones (data not shown). Whereas the paren-
tal ES cell line did not produce detectable levels of
immunoreactive EPO, the supernatant of the chosen
subclone contained 26 60.1 mU EPO/ml (n54).
Subsequently, the hEPO-overexpressing ES cell sub-
clone was allowed to differentiate to EBs at 20%
oxygen, and total RNA was extracted from growing
EBs every other day starting at differentiation day 4.
The presence of both endogenous and exogenous
EPO mRNA was analyzed by RT-PCR, using a specific
primer set for the mouse and human EPO gene.
Figure 5C shows two bands of the expected size in all
mRNA samples tested, implying that both EPO genes
were expressed during EB differentiation.
Total RNA from the same experiment was used to
study b-globin expression (Fig. 5D). Northern blot
analysis revealed a similar pattern of embryonic and
fetal/adult b-globin expression as was observed in
normoxically grown EBs derived from the untrans-
fected parental control ES cell line (compare Fig. 1A
and Fig. 5D): the bH-globin mRNA levels were
highest on days 6–8 of differentiation and strongly
declined after day 10. The bmaj-globin mRNA was
first detected at day 6, peaked at day 10, and de-
creased continuously until day 18. Thus, overexpres-
sion of hEPO does not influence the temporal
expression pattern of embryonic and fetal/adult
b-globin during EB differentiation.
DISCUSSION
Hypoxia influences b-globin switching in
developing EBs
Back in 1960, two independent groups observed that
exposure of reticulocytes isolated from umbilical
cord blood (46) or of cells derived from liver, spleen,
and bone marrow (47) to hypoxia/anoxia influ-
enced the relative rates of synthesis of adult and fetal
hemoglobin. Using EBs as an in vitro model of
embryogenesis, we demonstrate in the present work
that, under specific culture conditions, the ES cell-
derived EBs efficiently express embryonic bH1- and
fetal/adult bmaj-globin mRNA in a correct temporal
order. When EBs were grown at reduced oxygen
concentrations during the first 6 days of differentia-
tion, we observed a delayed but persistent bmaj-
globin expression pattern, whereas the temporal
expression of bH1-globin was not grossly altered
compared with the normoxic controls. We propose
that this temporal expression pattern at the mRNA
level reflects the situation in mouse embryo in utero
in which embryonic b-globin expression precedes
fetal/adult b-globin expression by several days (8).
The switch from embryonic to fetal/adult globin that
occurs between day 10 and 12 within the EBs, is
comparable to the switch described in the peripheral
blood at about embryonic day 12 (48).
Analysis of hemoglobin in EBs grown at varying
oxygen concentrations was performed by two inde-
pendent methods. DAF colorimetry and spectropho-
tometry both revealed the presence of early and late
waves of hemoglobin. Based on the bH1- and bmaj-
globin mRNA expression pattern, it is tempting to
speculate that the early wave represents yolk sac
erythropoiesis whereas the second wave mirrors the
switch to fetal liver erythropoiesis. Similarly, Wiles
Figure 4. HIF-1 expression in ES cells and EBs. A) Immuno-
blotting of HIF-1a and ARNT using normoxic (20% O2) and
hypoxic (1% O2 for 4 h) ES cell nuclear extracts. The filters
were incubated with anti-HIF-1a (left panel) or anti-ARNT
(right panel) polyclonal antibodies, as described in Materials
and Methods. B) Normoxic and hypoxic ES cell extracts were
analyzed for HIF-1 binding activity by EMSA. Supershift
analysis was performed with monoclonal antibodies derived
against HIF-1a and ARNT. C) Detection of HIF-1a mRNAs
derived from exon I.1 (371 bp) or I.2 (472 bp) in differenti-
ating EBs cultured at increasing oxygen concentrations was
performed using RT-PCR as described in Materials and
Methods.
values (dots). The wavelength of the light is given in nanometers (nm) and the degree of light absorption as optical density in
arbitrary units. The factors indicated reflect the degree of amplification required to obtain a comparable change in optical
density compared to the spectra at day 8. Note that the factors are in an inverse relationship to the hemoglobin content: the
higher the factor, the lower the hemoglobin content.
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and Keller (16) discussed the appearance of a late
wave of globinization in normoxic EBs at day 18 of
differentiation.
Favorable effects of hypoxia on EB development
EBs exposed to varying oxygen concentrations grew
equally well compared with the control EBs cultured
at normoxia, as judged by the average numbers of
cells within EBs. This agrees with two previous re-
ports in which we and others (17, 49) observed that
hypoxic exposure at the beginning of differentiation
did not impair the ES cells’ viability and had a
favorable effect on plating efficiency and hematopoi-
etic differentiation. These observations might be
explained by hypoxically induced expression of sev-
eral growth factors that interact in concert with each
other during EB development. In fact, EBs are
known to express a variety of oxygen-regulated
growth factors (17, 31, 45, 50, 51); two of them, EPO
(this work) and vascular endothelial growth factor
(17), were found to have increased steady-state
mRNA levels after hypoxic exposure of EBs. Apart
from differentiating ES cells, enhanced erythroid
colony formation has been observed when human
marrow was cultured at 5% oxygen (52).
By analogy to the observations in cell culture and
animal models, hypoxic induction of specific gene
transcription in EBs probably occurs via activation of
the ubiquitously expressed transcription factor
HIF-1, which in turn binds to the HIF-1 binding site
present in the flanking regions of oxygen-regulated
genes (36). Indeed, expression of HIF-1a and ARNT
was observed in all ES cells tested. Moreover, we
found that both HIF-1a isoforms that emerge from
two alternative first exons (25) were expressed in
developing EBs. Whether these two isoforms, one
being expressed from a tissue-specific and the other
from a housekeeping-type promoter (40), have dis-
tinct physiological functions during differentiation
remains to be elucidated. Together, we propose that,
upon reduced oxygen supply and HIF-1 activation,
EBs are capable of inducing required (growth) fac-
tors, which in turn support their own differentiation.
Figure 5. Expression of EPO, EPO-R, embryonic (bH1) and
fetal/adult (bmaj) globin in differentiating EBs. A) Total RNA
samples (1 mg) isolated from wild-type EBs at the indicated
time points were reverse-transcribed, PCR-amplified, and the
reaction products were electrophoresed through 1.4% aga-
rose gels. The diagnostic RT-PCR products are 395 bp and
452 bp for EPO and EPO-R, respectively. B) Specific EPO
mRNA in 9 day old wild-type EBs was quantitated by compet-
itive RT-PCR using a competitor cRNA template. EBs were
preincubated at 20% or 1% O2 for 24 h prior to exposure to
1% or 20% O2, respectively, for 4 h. The RT-PCR products for
EPO and competitor were quantitated by pixel analysis of a
video camera recording. EPO mRNA levels are expressed as
mean 6sd of 4 to 8 experiments. C) Total RNA from hEPO-
overexpressing EBs was analyzed for the presence of both
mouse and human EPO mRNA. The diagnostic bands are 395
bp and 280 bp for mouse and human EPO, respectively. Total
RNA extracted from kidney of hypoxic mice was used as
positive control for endogenous EPO mRNA expression. D)
An ES cell subclone stably transfected with an hEPO-overex-
pressing vector was used to generate EBs in normoxic condi-
tions (20% O2). Each 10 mg of total RNA extracted from
growing EBs at different time points were analyzed for bH1
and bmaj-globin expression by Northern blotting. A ribosomal
protein L28 probe was used as a control for loading and
transfer efficiency.
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EPO gene expression in EBs
Based on an early report suggesting that EPO might
be involved in the fetal to adult hemoglobin switch
(53), we generated EBs derived from an EPO-over-
expressing ES cell subline. However, the kinetics of
bH1 and bmaj-globin mRNA expression was not
altered in EPO-overexpressing EBs (26 mU EPO/
ml). This agrees with a previous report showing that
addition of recombinant EPO (2000 mU/ml) did
not influence the kinetics of b-globin mRNA expres-
sion (16). The abundance of both b-globins, how-
ever, was reported to be about threefold stronger in
the presence of exogenous EPO. In contrast, we did
not observe a similar effect by overexpressing EPO in
our EBs. This discrepancy might be explained by the
lower and perhaps more physiological concentra-
tions of EPO expressed from transfected cells within
the EBs and/or by different posttranslational modi-
fications.
Expression of EPO and EPO-R during the earliest
stages of EB development prior to the onset of
erythropoiesis raised the question of whether EPO
plays a yet unknown developmental function apart
from erythropoiesis (reviewed in ref 54). Knowing,
for instance, that EPO has a mitogenic and chemo-
tactic effect on endothelial cells that express EPO-R
(55, 56), one might postulate that EPO is involved in
angiogenesis and/or vascular development. On the
other hand, expression of EPO and EPO-R in the
mammalian (including human) brain (21, 57–61)
allows to speculate that EPO is involved in brain
development. In analogy to its function during eryth-
ropoiesis, where EPO prevents apoptosis of erythroid
progenitor cells (42), EPO might be involved in the
regulation of apoptosis in the developing brain.
How does hypoxia influence b-globin switching in
EBs?
As concluded from the above observations, EPO
alone does not influence b-globin switching in de-
veloping EBs. How, then, is this switch regulated?
One possibility is that the transcription factor HIF-1
activates a yet unknown gene, which in turn modu-
lates b-globin expression. On the other hand, one
might postulate that HIF-1 binds directly to a puta-
tive HIF-1 binding site present in the locus control
region or promoters of the b-globin cluster, thereby
repressing embryonic globin expression and/or ac-
tivating fetal/adult globin expression. In a com-
puter-assisted search using A/(G)CGTG as query
(35), putative HIF-1 binding sites were detected in
the b-globin locus control region. Knowing that
binding to this consensus sequence might be influ-
enced by the neighboring nucleotides as well as by
adjacent sites for other transcription factors (36),
these putative HIF binding sites have to be analyzed
for functionality by EMSA and transient transfection
experiments. Understanding the molecular mecha-
nism(s) of b-globin gene regulation is a prerequisite
for therapeutic treatment of patients suffering from
b thalassaemia and sickle cell anemia. Once these
mechanims are fully understood, one might envision
the possibility of altering the switch from embry-
onic/fetal to adult hemoglobin production in pa-
tients.
Evidence for the need of a hypoxic environment
for normal development
Hypoxic modulation of b-globin switching supports
our hypothesis that a low oxygen environment found
in utero is mandatory for the early embryo to express
oxygen-regulated genes in the correct temporal or-
der, thereby ultimately driving their development
(17). Around midgestation, the capillary network is
present, allowing efficient oxygen supply to the
tissue and thereby decreasing hypoxia-induced gene
expression to constitutive levels. Targeted disruption
of HIF-1a, the master regulator of oxygen homeosta-
sis, resulted in embryonic lethality at around mid-
gestation due to cardiovascular malformations and
neuronal defects (39, 62). Further evidence in sup-
port of our hypothesis came from recent studies
showing that null mutant mice lacking ARNT, the
heterodimerization partner of HIF-1a, also died at
midgestation. The ARNT-deficient fetuses were re-
ported to suffer from defective angiogenesis of the
yolk sac and solid tissues (63) or from a failure to
develop the embryonic component of the placenta
to vascularize and form the labyrinthine spongiotro-
phoblast (64). In keeping with this, it has been
reported that human cytotrophoblasts continued
proliferating and differentiated poorly when cul-
tured at 2% oxygen, a concentration mimicking the
uterine conditions at wk 10 of gestation. In contrast,
when grown at 20% oxygen, the cells stopped prolif-
erating and differentiated normally (65). Thus, the
uterine oxygen tension regulates placental growth.
Additional evidence in support of our hypothesis
awaits studies of the developing embryo in which the
oxygen concentration has been altered in vivo.
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